WASHINGTON (AP) - U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.
from www.washingtontimes.com stories: Health https://ift.tt/2GKPpIF
WASHINGTON (AP) - U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.